Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Agree. The chart also should give us a direction soon.
I am with you and Boo. However I concern more about volume than price.
Do you think at current PPS, call option 2015 or 2016 is a better pick? I am watching strike 2 or 2.5.
What happened in last few seconds?
16:00:03 $ 2.92 14,500
16:00:03 $ 2.92 405
16:00:03 $ 2.92 500
16:00:03 $ 2.92 180
16:00:03 $ 2.92 137,737
16:00:03 $ 2.92 87
16:00:03 $ 2.92 1,497
16:00:03 $ 2.92 171,144
16:00:03 $ 2.92 743,000
16:00:03 $ 2.92 712
16:00:03 $ 2.92 7,000
16:00:03 $ 2.92 6,100
16:00:03 $ 2.92 1,322
16:00:00 $ 2.92 1,084,184
Read more: http://www.nasdaq.com/symbol/gale/time-sales#ixzz2wd79KDFz
Super quiet especially after 11:30 AM. No buying and no selling.
Look forward see a drama-free and peaceful trading day...
Nice to see you covering this cursed security!!!
Mara Goldstein is THESTREET's friend.
Good volume even after 1030AM.
I want to see the volume after 10am. And from data on CNBC, it seems institutions still hold good position. Anyway, today will be bloody.
BD, did you figure out why cash increased from 12/31/13 to 03/14/2014?
Most loss is not from operation. Operation loss for 2013 whole year is $.46 around.
Hard decision have to make today.
The only reason for me to hold GALE is:
"As of December 31, 2013, Galena had cash and cash equivalents of $47.8 million, compared with $32.8 million as of December 31, 2012. As of March 14, 2014, Galena had cash and cash equivalents of $55.3 million."
I don't know why after 2.5 months, its cash is increased not decreased. Where the 8 million dollars cash from? Investing or operating?
I am on the edge of breakeven so I am lost here.
The report disappoints me. I am losing confidence on MGMT now.
Too much mixed information. Get ready to be really LONG if you really want to be long.
Let's see how institutions read this report. AH is nothing.
Hope it is a mistake only.
17:00 $ 3.14 Low 68,898
Numbers did not give us enough support. However, completion of NeuVax Phase III enrollment give us a big pix.
Before earnings report, I don't think there will be a big jump.
Seems article from AF did not work today, as least so far. Next Monday will be a big day for Long and Short.
I buy for Abstral and NeuVax is a bonus.
Very good advice and actually take it all. I am reviewing my trading not-so-long trading history and set a better rule (a rule to be followed not set).
Yes, I really think it might reach $10 PPS in 2014 some day by Abstral alone. I expect $15 MM sales in 3rd quarter and $20 MM sales in 4th quarter. I must grant myself enough blessings.
Good luck to all of us. Let's see next Monday AH.
I saw your post about ASCO 2014. And at that time the 1st quarter report should be available too. It is too late to sell even there is a room to get lower, right?
I got some CERE last week but I dumped today with 3% loss.
Subsys sales in 4th quarter is $40 MM with 28.3% market share;
Abstral gained 5% market share, so 4th quarter sales should be $5-7 MM if both Subsys and Abstral have similar coupon/promotion.
Price per dose for Subsys and Abstral are very similar (from $880-2600).
This is the reason why I did not dump it.
What is your DD?
The best defending from board of director is a nice annual report. Or all of us are in big trouble.
CYTR is backing up but not GALE?
Let's see data, trial data and abstral sales data. 3 business days away from Abstral data.
Anybody have copy of those articles published by Dream Team?
BD, I think you are looking for 200 days average. Let's say in next 3-6 months, we do you expect from GALE?
I have been thinking about Abstral Sales for couple days. Got a few point.
1. Abstral gain at least 5 percent prescription of market share and double digit in 2nd half;
2. Market cap is $400 MM;
3. Most prescription is generic.
Conclusion: 5% prescription share >> 5% market cap. I expect 4th quarter Abstral sales over 5MM.
I only see sell and no buy today. A very bad is expected. So let's wait to see what happen on next Monday 4pm.
Instead, I don't worry lawsuits. They will be dismissed in early of May. And by that time, 2014 1st quarter report is coming.
I really don't understand figures below:
1. 2014 Abstral Sales $8-12 million;
2. Positive cash flow in 2nd half 2014.
If total operative cash flow is to be positive, we need at least $10-12 million sales/quarter.
Anyway, 7 more days to wait to see the actual figures and outlook.
PPS is keeping dropping after Conference. Any news?
Can anyone post conference transcript if you are listening? I cannot do it in office. Thanks.
so easy, click a member' name on this board and click "ignore this member". Board is clean to me now.
I expect a good report on 03/17 which can also defense directors' selling not supported by DTG's article. However, recent PPS really gives me a lot pressure.
GALE is seeking for $3.6 support or no support at all?
I must raise my hand!
This article bashed about 10,000 shares in AH.